oral tirzepatide development status TrimRX Safety and efficacy of tirzepatide

Body composition analyzer (InBody): This scan sends safe, low-level electrical currents through the body to measure impedance (resistance)

About 1.6 million adults in England, Scotland and Wales are estimated to have used GLP-1s for weight loss between early 2024 and early 2025, according to recently published research by University College London

Seong AH, Lii YI, Lee J, Choi S, Kim IA, Suk J, et al

Overall, the relative analysis reported a greater risk of thyroid cancer in patients prescribed GLP-1RA medications as compared to those using other medications

Discuss individual risk tolerance and priorities with your doctor when retatrutide becomes available